Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4 | 22 | 0 | 0 | N/A |
| TOTAL | $4 | $22 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | N/A | N/A | N/A |
| TOTAL | $1 | $1 | $N/A | $N/A | $N/A |
| Total Assets | $5 | $23 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1 | 2 | 3 | 3 | 0 |
| TOTAL | $2 | $3 | $4 | $4 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2 | $3 | $4 | $4 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 195 | N/A | 170 | 170 | N/A |
| Common Shares | 6 | 6 | 5 | 5 | N/A |
| Retained earnings | -44 | -27 | -14 | -14 | N/A |
| TOTAL | $3 | $20 | $-4 | $-4 | $N/A |
| Total Liabilities And Equity | $5 | $23 | $0 | $0 | $0 |